Compare Honest Company Inc (HNST) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Honest Company Inc vs Medtronic PLC — how do they compare? Honest Company Inc trades at $3.88 (market cap $426.55M), while Medtronic PLC trades at $82.63 (market cap $106.61B). The key difference: Medtronic PLC is far larger — about 249.9× Honest Company Inc's market cap, and Medtronic PLC pays a 3.46% dividend while Honest Company Inc pays none. Which is the better fit depends on your goals.
| HNST | MDT | |
|---|---|---|
Market Cap | $426.55M | $106.61B |
Sector | Consumer Staples | Health |
52-Week High | $4.95 | $105.35 |
52-Week Low | $2.10 | $73.75 |
Enterprise Value | $347.95M | $125.36B |
Dividend Yield | — | 3.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HNST trades at $3.89, up 1.57% with a bullish technical signal. The company shows mixed fundamentals with revenue of $371.32M in 2025 but negative net income of -$15.69M. Recent earnings show one beat and two misses, while cash flow improved to $14.15M net. Analyst consensus is divided with 30% buy, 50% hold ratings. The company announced Q2 2026 results for August 5, 2026, alongside leadership updates.
Outlook remains cautious due to persistent losses and margin pressure, though strategic shifts to retail and cost controls offer potential. Key risks include competitive intensity and execution challenges. The stock presents speculative appeal for turnaround believers but requires monitoring of profitability improvements.
Medtronic (MDT) trades at $82.35, down 1.02% on the day, with a bullish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS expected at $1.39. Revenue grew to $33.54B in 2025, with a net income margin of 13.2%. Recent news highlights the acquisition of SPR and the launch of AI-powered surgical technology, signaling innovation-driven growth.
The outlook for MDT is positive, supported by analyst consensus with a $97.50 price target and 58% buy ratings. Key opportunities include robust cash flow and dividend stability, while risks involve rising debt levels and competitive pressures in medtech. The stock presents a value proposition with a P/E of 22.33, trading below the consensus target.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Honest Company Inc
The Honest Co Inc is a consumer products company. It offers eco-friendly diapers and a natural line of bath, skincare, home cleaning, and organic nutritional supplement products and other products.
Read more on HNST →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
